Aerosol Production During Blood and Urine Pre-analytical Processing and Handling in a Hospital Biochemistry Clinical Laboratory During the COVID-19 Pandemic.

SARS-CoV-2 bioaerosols blood sample clinical laboratory occupational risk urine sample

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2021
Historique:
received: 18 12 2020
accepted: 25 03 2021
entrez: 10 5 2021
pubmed: 11 5 2021
medline: 13 5 2021
Statut: epublish

Résumé

The SARS-CoV-2 pandemic has created a troublesome issue for employees in biochemistry clinical laboratories due to fears of aerosol generation during sample treatment. This study was designed to assess aerosol production during the pre-analytical procedures for blood and urine samples using a model bacterium. Air sampling and surface swabbing were conducted during four typical procedures. Bacteria were not recovered in any air or surface samples. Other studies have reported low and undetectable SARS-CoV-2 RNA in blood and urine samples, respectively. Therefore, the occupational risk for employees appears to be low in terms of aerosol exposure from processing SARS-CoV-2 patient samples.

Identifiants

pubmed: 33968882
doi: 10.3389/fpubh.2021.643724
pmc: PMC8097034
doi:

Substances chimiques

Aerosols 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

643724

Informations de copyright

Copyright © 2021 Dubuis and Duchaine.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Med Virol. 2020 Sep;92(9):1676-1680
pubmed: 32330305
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Wellcome Open Res. 2020 Jul 29;5:181
pubmed: 33283055
Int J Biol Sci. 2020 Mar 15;16(10):1698-1707
pubmed: 32226287
J Appl Microbiol. 2006 Apr;100(4):658-63
pubmed: 16553720

Auteurs

Marie-Eve Dubuis (ME)

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, QC, Canada.
Faculté des Sciences et de Génie, Département de Biochimie, de Microbiologie et de Bio-informatique, Université Laval, Quebec, QC, Canada.

Caroline Duchaine (C)

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, QC, Canada.
Faculté des Sciences et de Génie, Département de Biochimie, de Microbiologie et de Bio-informatique, Université Laval, Quebec, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH